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Gestodene is a steroidal progestogen contraceptive and 
it exhibits dimorphism [1]. Both polymorphs have an 
orthorhombic structure with space group P212121. The 
specific volumes obtained from the unit cell dimensions at 
room temperature are 0.841 cm3 g-1 for polymorph I and 
0.850 cm3 g-1 for polymorph II. It demonstrates that form 
I is denser than form II and its stability should therefore 
increase with increasing pressure. 
 
The pressure-temperature phase diagram of gestodene 
is constructed using the temperature and enthalpy of 
fusion of form I (469.5 K, 107 J g-1), and those of the 
endothermic transition from form II to form I (311 K, 8.52 
J g-1). At ordinary pressure, the sign of the enthalpy is 
positive indicating an endothermic transition and implying 
that the two polymorphs are enantiotropically related. 
 
The melting temperature of form II has not been 
obtained experimentally; however, it can be obtained by 
calculation using the expression:  
 𝑇""→$ = ∆''→'()∆'→*(∆''→'+,''→' )∆'→*+,'→* 	 	 	 (1)	
 
 
This leads to a melting temperature for form II of about 
452 K, obviously lower than that of form I, which 
possesses the stable melting temperature. However, 
considering the IIàI transition occurring at 311 K, it can 
be concluded that form II is the stable form at room 
temperature. Using the inequality in the specific volumes 
and in the enthalpy and applying them in the Clapeyron 
equation, it is shown that the two polymorphs remain 
enantiotropically related on increasing the pressure since 
the dP/dT slope of the I-II equilibrium line is found to be 
negative while that of the I-liquid equilibrium is positive 
(Figure 1) as it is usually the case for a molecular liquid, 
which has necessarily a higher entropic content than that 
of the solid state and a lower density than that of the solid 
state (Water in this respect is a very rare exception due to 
its higher density in the liquid state than in the solid state). 
 
In addition, it is shown that the heats of dissolution, 
inferred from solubility measurements, lead to virtually 
the same value of the heat of transition from polymorph II 
to polymorph I as the value obtained by differential 
scanning calorimetry [2]. 
From a pharmaceutical perspective, it implies that 
logically form II is the most appropriate form to develop, 
however, due to the low transition temperature of 311 K 
(38 °C) and the fact that form I is stabilized in relation to 
form II as a function of pressure, it is important to monitor 
the polymorphism of this particular drug during 
processing, because the chances are very high on grinding 
or compressing the sample that form I could temporarily 
appear with a possible risk to alter the bioavailability of 
gestodene in the formulation. 
 
 
 
 
Figure 1. Topological P-T phase diagram for the dimorphism of 
gestodene with the triple points: 1= stable I-liq-vap, 2 = 
metastable II-liq-vap, 3= metastable I-II-liq, 4 = stable I-II-vap. 
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